Drug Testing Locations - Asbury Park, NJ

Drug Testing in Asbury Park, NJ

Asbury Park, New Jersey Statistics

In 2022, Monmouth County recorded over 1,200 cases of drug-related arrests, predominantly within Asbury Park.

A county health report indicated that Monmouth County had a 15% increase in opioid-related overdoses from 2021 to 2022.

In 2023, Asbury Park reported a 10% decrease in new drug-related incarcerations compared to the previous year.

Monmouth County's 2022 addiction services showed a 25% increase in participants from Asbury Park seeking treatment for substance abuse.

The city's education department highlighted that 12% of students in Asbury Park schools reported recreational drug use in 2022.

A 2023 community survey revealed that 38% of Asbury Park residents consider drug abuse a top local issue.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Asbury Park, NJ & Drug Testing Policies

Employers in Asbury Park, NJ, increasingly recognize the importance of maintaining drug-free workplaces. Many local businesses have implemented comprehensive drug testing policies in alignment with New Jersey state guidelines. According to the New Jersey Business Portal, companies are encouraged to adopt clear policies and conduct regular employee training to address drug use concerns.

The City of Asbury Park also works closely with its employers to emphasize the significance of maintaining safe and productive work environments. Random drug testing, reasonable suspicion testing, and post-accident testing are common practices among the city's employers. For resources on establishing drug policies, employers can consult the U.S. Department of Labor.

Government Efforts with Drug Problems in Asbury Park, NJ

The government of Asbury Park, in collaboration with Monmouth County, has intensified efforts to tackle the city's drug problems. Initiatives include increased funding for rehabilitation centers and community outreach programs. The city has also partnered with the New Jersey Department of Law & Public Safety to enhance law enforcement training on substance abuse issues.

Moreover, Asbury Park is actively involved in state-wide initiatives such as the Opioid Response Team, sponsored by the New Jersey Department of Health. This program aims to educate the community and reduce opioid misuse through targeted interventions and awareness campaigns. More information can be accessed by visiting the New Jersey Department of Health.

Local Drug Busts & News in Asbury Park, NJ

Recently, Asbury Park has seen heightened law enforcement activity due to a series of local drug busts. The city, located along the Jersey Shore, has been proactively tackling the issue of illegal narcotics. Local police, in collaboration with neighboring departments, have increased patrols and surveillance to curb the distribution of substances such as heroin and cocaine.

Community members have expressed both concern and relief following these events. While the presence of drugs in the area raises alarms about safety and health, the successful operations conducted by law enforcement are seen as a positive step toward restoring peace in neighborhoods. Residents have been encouraged to report suspicious activities to aid in ongoing investigations.

Efforts to address drug-related problems in Asbury Park are not limited to policing. Local organizations have ramped up outreach programs aimed at education and rehabilitation. These initiatives are designed to provide support to those struggling with addiction, offering resources that go beyond punitive measures and focus on recovery and prevention.

Despite the challenges, Asbury Park officials remain optimistic about their strategies to combat drug-related activities effectively. By combining law enforcement efforts with community support and educational programs, the city hopes to foster a safer environment for its residents. Continuous collaboration between various stakeholders is seen as crucial in maintaining progress.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Asbury Park, NJ. Trusted by employers nationwide for accurate results and exceptional service.

New Jersey DOT/Non DOT Physicals

New Jersey Vision Tests

New Jersey Audiograms

New Jersey Respirator Fit Tests

New Jersey Lift Tests

New Jersey Background Checks

Clinical Testing Services

TB Testing in NJ

Diabetes Testing in NJ

Infectious Disease Testing in NJ

Sickle Cell Anemia Testing in NJ

Women/Men's Health Testing in NJ

Resources & Citations

National Institute on Drug Abuse

Substance Abuse and Mental Health Services Administration

Stop Overdose

New Jersey Office of the Attorney General

Monmouth County Health Department

City of Asbury Park

NJ CARE

Recovery Resource

NCADD of New Jersey

Partnership for Drug-Free Kids

Drug Testing Near Asbury Park, NJ

Pedricktown, NJ

Green Grove, NJ

Lake Como, NJ

Oakhurst, NJ

Belmar, NJ

Shark River Hills, NJ

Deal, NJ

Avon-by-the-Sea, NJ

Neptune City, NJ

Wanamassa, NJ

Bradley Beach, NJ

Allenhurst, NJ

Interlaken, NJ

Loch Arbour, NJ

Ocean Grove, NJ

Frequently Asked Questions

Customer Reviews